‘2016 State of Innovation Report’: Biotech innovation decreases by 2%

Biotech was the only technology area out of 12 studied that has shown a global decline in its year-on-year innovation, declining by 2%, according to the “2016 State of Innovation Report: Disruptive, Game-Changing Innovation” by Thomson Reuters.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead awarded $30m over counterfeit HIV drug scheme

EPO invalidates human milk patent after Nestle opposition

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

‘2016 State of Innovation Report’: Biotech innovation decreases by 2%

Editor's picks

Editor's picks

More features